Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ALT5 Sigma (ALTS) Cash & Equivalents (2016 - 2025)

ALT5 Sigma (ALTS) has disclosed Cash & Equivalents for 16 consecutive years, with $7.3 million as the latest value for Q3 2025.

  • Quarterly Cash & Equivalents fell 15.58% to $7.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Sep 2025, down 15.58% year-over-year, with the annual reading at $7.2 million for FY2024, 143440.0% up from the prior year.
  • Cash & Equivalents for Q3 2025 was $7.3 million at ALT5 Sigma, down from $9.6 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $10.8 million in Q1 2025, with the low at $5000.0 in Q4 2023.
  • Average Cash & Equivalents over 5 years is $3.4 million, with a median of $1.7 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents plummeted 91.8% in 2023, then skyrocketed 143440.0% in 2024.
  • Over 5 years, Cash & Equivalents stood at $2.8 million in 2021, then plummeted by 97.84% to $61000.0 in 2022, then tumbled by 91.8% to $5000.0 in 2023, then surged by 143440.0% to $7.2 million in 2024, then increased by 1.96% to $7.3 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $7.3 million, $9.6 million, and $10.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.